GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 319 filers reported holding GW PHARMACEUTICALS PLC in Q3 2019. The put-call ratio across all filers is 0.65 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $19,578,000 | +285.4% | 90,267 | +105.0% | 0.36% | +201.7% |
| Q4 2020 | $5,080,000 | +140.2% | 44,030 | +102.5% | 0.12% | +50.0% |
| Q3 2020 | $2,115,000 | +38.6% | 21,738 | +74.8% | 0.08% | +1.3% |
| Q2 2020 | $1,526,000 | +55.6% | 12,437 | +10.9% | 0.08% | +17.9% |
| Q1 2020 | $981,000 | +99.0% | 11,214 | +162.5% | 0.07% | +109.4% |
| Q4 2019 | $493,000 | +82.6% | 4,272 | +81.6% | 0.03% | +39.1% |
| Q3 2019 | $270,000 | – | 2,352 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management, LLC | 311,853 | $25,213,000 | 11.33% |
| Iguana Healthcare Management, LLC | 50,000 | $4,043,000 | 2.16% |
| Ghost Tree Capital, LLC | 35,000 | $2,830,000 | 1.54% |
| CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD | 354,278 | $28,643,000 | 1.06% |
| Cupps Capital Management, LLC | 100,213 | $8,102,000 | 0.75% |
| CLOUGH CAPITAL PARTNERS L P | 192,600 | $15,572,000 | 0.58% |
| FARALLON CAPITAL MANAGEMENT LLC | 244,000 | $19,727,000 | 0.32% |
| CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD | 105,200 | $8,505,000 | 0.31% |
| Eventide Asset Management | 25,000 | $2,021,000 | 0.28% |
| PRUDENTIAL PLC | 836,124 | $67,601,000 | 0.28% |